Lundbeckfond Invest A/s - Net Worth and Insider Trading
Lundbeckfond Invest A/s Net Worth
The estimated net worth of Lundbeckfond Invest A/s is at least $39 Million dollars as of 2025-05-25. Lundbeckfond Invest A/s is the 10% Owner of scPharmaceuticals Inc and owns about 3,183,986 shares of scPharmaceuticals Inc (SCPH) stock worth over $11 Million. Lundbeckfond Invest A/s is the 10% Owner of Imara Inc and owns about 1,432,722 shares of Imara Inc (IMRA) stock worth over $9 Million. Lundbeckfond Invest A/s is also the 10% Owner of IO Biotech Inc and owns about 6,049,452 shares of IO Biotech Inc (IOBT) stock worth over $7 Million. Besides these, Lundbeckfond Invest A/s also holds Trevi Therapeutics Inc (TRVI) , Lexeo Therapeutics Inc (LXEO) . Details can be seen in Lundbeckfond Invest A/s's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Lundbeckfond Invest A/s has not made any transactions after 2023-11-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Lundbeckfond Invest A/s
Lundbeckfond Invest A/s Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Lundbeckfond Invest A/s owns 8 companies in total, including Imara Inc (IMRA) , Trevi Therapeutics Inc (TRVI) , and scPharmaceuticals Inc (SCPH) among others .
Click here to see the complete history of Lundbeckfond Invest A/s’s form 4 insider trades.
Insider Ownership Summary of Lundbeckfond Invest A/s
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| IMRA | Imara Inc | 2020-03-16 | 10 percent owner |
| TRVI | Trevi Therapeutics Inc | 2019-05-09 | 10 percent owner |
| SCPH | scPharmaceuticals Inc | 2017-11-21 | 10 percent owner |
 | | 2017-11-01 | 10 percent owner |
| | 2014-01-29 | 10 percent owner |
| | 2021-11-09 | 10 percent owner |
| | 2020-03-11 | 10 percent owner |
| | 2023-11-07 | 10 percent owner |
Lundbeckfond Invest A/s Latest Holdings Summary
Lundbeckfond Invest A/s currently owns a total of 5 stocks. Among these stocks, Lundbeckfond Invest A/s owns 3,183,986 shares of scPharmaceuticals Inc (SCPH) as of November 21, 2017, with a value of $11 Million and a weighting of 26.79%. Lundbeckfond Invest A/s owns 1,432,722 shares of Imara Inc (IMRA) as of March 16, 2020, with a value of $9 Million and a weighting of 23.02%. Lundbeckfond Invest A/s also owns 6,049,452 shares of IO Biotech Inc (IOBT) as of November 9, 2021, with a value of $7 Million and a weighting of 18.61%. The other 2 stocks Trevi Therapeutics Inc (TRVI) , Lexeo Therapeutics Inc (LXEO) have a combined weighting of 31.58% among all his current holdings.
Latest Holdings of Lundbeckfond Invest A/s
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SCPH | scPharmaceuticals Inc | 2017-11-21 | 3,183,986 | 3.31 | 10,538,994 |
| IMRA | Imara Inc | 2020-03-16 | 1,432,722 | 6.32 | 9,054,803 |
| IOBT | IO Biotech Inc | 2021-11-09 | 6,049,452 | 1.21 | 7,319,837 |
| TRVI | Trevi Therapeutics Inc | 2019-05-09 | 1,151,544 | 6.29 | 7,243,212 |
| LXEO | Lexeo Therapeutics Inc | 2023-11-07 | 1,835,959 | 2.82 | 5,177,404 |
Holding Weightings of Lundbeckfond Invest A/s
Lundbeckfond Invest A/s Form 4 Trading Tracker
According to the SEC Form 4 filings, Lundbeckfond Invest A/s has made a total of 0 transactions in scPharmaceuticals Inc (SCPH) over the past 5 years. The most-recent trade in scPharmaceuticals Inc is the acquisition of 654,762 shares on November 21, 2017, which cost Lundbeckfond Invest A/s around $9 Million.
According to the SEC Form 4 filings, Lundbeckfond Invest A/s has made a total of 0 transactions in Imara Inc (IMRA) over the past 5 years. The most-recent trade in Imara Inc is the acquisition of 187,500 shares on March 16, 2020, which cost Lundbeckfond Invest A/s around $3 Million.
According to the SEC Form 4 filings, Lundbeckfond Invest A/s has made a total of 1 transactions in IO Biotech Inc (IOBT) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in IO Biotech Inc is the acquisition of 2,142,857 shares on November 9, 2021, which cost Lundbeckfond Invest A/s around $30 Million.
More details on Lundbeckfond Invest A/s's insider transactions can be found in the Insider Trading History of Lundbeckfond Invest A/s table.Insider Trading History of Lundbeckfond Invest A/s
- 1
Lundbeckfond Invest A/s Trading Performance
GuruFocus tracks the stock performance after each of Lundbeckfond Invest A/s's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Lundbeckfond Invest A/s is 28.2%. GuruFocus also compares Lundbeckfond Invest A/s's trading performance to market benchmark return within the same time period. The performance of stocks bought by Lundbeckfond Invest A/s within 3 months outperforms 3 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Lundbeckfond Invest A/s's insider trading performs compared to the benchmark.
Performance of Lundbeckfond Invest A/s
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 1.21 | | | | | |
| Relative Return to S&P 500(%) | -3.8 | | | | | |
Lundbeckfond Invest A/s Ownership Network
Ownership Network List of Lundbeckfond Invest A/s
Ownership Network Relation of Lundbeckfond Invest A/s
Lundbeckfond Invest A/s Owned Company Details
What does Imara Inc do?
Who are the key executives at Imara Inc?
Lundbeckfond Invest A/s is the 10 percent owner of Imara Inc. Other key executives at Imara Inc include director & President & CEO Rahul D. Ballal , See Remarks Michael Gray , and 10 percent owner Braden Michael Leonard .
Imara Inc (IMRA) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Imara Inc (IMRA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Imara Inc (IMRA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Imara Inc (IMRA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Imara Inc Insider Transactions
Lundbeckfond Invest A/s Mailing Address
Above is the net worth, insider trading, and ownership report for Lundbeckfond Invest A/s. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Lundbeckfond Invest A/s's mailing address is: Copenhagen G7 Dk-2100.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
